Skip to main content
. 2021 Mar 17;10(2):126–136. doi: 10.1159/000513404

Table 4.

Distribution of patients in the different staging systems at the time of each procedure

MELD Points
 Minimum value 6
 1st quartile 8
 Median 9
 3rd quartile 10
 Maximum value 29
ITA.LI.CA, n (%)
 0–1 307 (19.1)
 2 395 (24.5)
 3 433 (26.9)
 ≥4 475 (29.5)
CLIP, n (%)
 0 470 (29.2)
 1 633 (39.3)
 2 436 (27.1)
 3 65 (4.1)
 4 6 (0.3)
 5 0 (0)
MESH, n (%)
 0 394 (24.5)
 1 682 (42.4)
 2 396 (24.6)
 3 122 (7.5)
 4 15 (0.9)
 5 1 (0.1)
MESIAH
 Minimum value 3.759
 1st quartile 5.222
 Median 5.641
 3rd quartile 6.032
 Maximum value 8.876
JIS, n (%)
 0 155 (9.6)
 1 603 (37.5)
 2 743 (46.2)
 3 105 (6.5)
 4 4 (0.2)
 5 0 (0)
HKCL, n (%)
 I 888 (55.2)
 IIa 281 (17.4)
 IIb 243 (15.1)
 IIIa 29 (1.8)
 IIIb 65 (4.1)
 IVa 56 (3.5)
 IVb 8 (0.5)
 Va 30 (1.8)
 Vb 10 (0.6)

1,610 procedures were performed in 1,058 patients. The table reports the distribution of patients at the time of each procedure. Therefore, data from the same patient may have been included >1 time. ITA.LI.CA, Italian Liver Cancer; CLIP, Cancer of the Liver Italian Program; MESH, model to estimate survival for hepatocellular carcinoma; MESIAH, Model to Estimate Survival In Ambulatory HCC patients; JIS, Japan Integrated Staging system; HKLC, Hong Kong Liver Cancer.